warfarin


Also found in: Dictionary, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to warfarin: heparin
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for warfarin

an anticoagulant (trade name Coumadin) use to prevent and treat a thrombus or embolus

References in periodicals archive ?
Since warfarin readily crosses the placenta, it is implicated in two major adverse effects.
Factors linked to reduced likelihood of warfarin discontinuation included comorbid atrial fibrillation, which was associated with a 25% reduction in risk of discontinuation; thrombophilia, with a 34% relative risk reduction; and pulmonary embolism, with a 24% reduction in discontinuation compared to patients with DVT only.
Arbitrary warfarin dose adjustment frequently overcorrects the INR.
However, the risk of certain types of serious bleeding, including in the brain, is lower with these drugs as compared warfarin.
Studies have shown that DNA testing can potentially improve the safety and effectiveness of warfarin, said Kirk Voelker, M.
Although GBE is also believed to increase the risk of bleeding by its interaction with anticoagulants such as warfarin (Matthews 1998; Ulbricht et al.
Eisai estimates that there are approximately one million patients currently taking Warfarin in Japan.
The new medication also lacks the long list of drugs, foods and supplements that can interact adversely with warfarin and alter its effects.
114 were to the anticoagulant group (Group I) and104 to the warfarin withdrawn group (Group II).
Warfarin is the most commonly used oral anticoagulant and has been used in preventing thromboembolic events in patients with chronic arterial fibrillation, prosthetic heart valves, venous thrombosis canonry hear disorders.
At his next visit to the doctor for a warfarin test, raise the possibility of reviewing your husband's gout medication and having physiotherapy.
The variability in warfarin dosing depends on several factors, including demographics, the environment, and genetics.
This has led physicians to avoid the measurement of antithrombin when patients were receiving warfarin for treatment of a thrombotic event.
Current recommendations and labeling regarding the use of dabigatran will not change, based on the results of a large observational cohort study comparing the risks of the direct thrombin inhibitor and warfarin in Medicare recipients, the Food and Drug Administration announced.
Now that we in in the midst of the flu season, it is important to realize that patients who are on a Warfarin regimen may face some unexpected risks.
Full browser ?